NovaBay Pharmaceuticals Files 8-K
Ticker: NBY · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1389545
Sentiment: neutral
Topics: filing, regulatory
Related Tickers: NBY
TL;DR
NovaBay filed an 8-K on Oct 20, 2025. Details to follow.
AI Summary
NovaBay Pharmaceuticals, Inc. filed an 8-K on October 21, 2025, reporting on events that occurred on October 20, 2025. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events detailed in the provided text beyond the filing itself.
Why It Matters
This filing indicates that NovaBay Pharmaceuticals, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors regarding the company's operations or financial status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and exhibits, and the provided text does not contain specific negative or positive material information.
Key Players & Entities
- NovaBay Pharmaceuticals, Inc. (company) — Registrant
- October 20, 2025 (date) — Date of earliest event reported
- October 21, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-33678 (identifier) — Commission File Number
- 68-0454536 (identifier) — IRS Employer Identification No.
- 2000 Powell Street, Suite 1150, Emeryville, CA 94608 (address) — Principal executive offices
- (510) 899-8800 (phone_number) — Registrant's telephone number
FAQ
What specific "Other Events" are being reported by NovaBay Pharmaceuticals, Inc. on October 20, 2025?
The provided text of the 8-K filing does not specify the details of the "Other Events" beyond listing the item information category.
What "Financial Statements and Exhibits" are included with this 8-K filing?
The provided text of the 8-K filing lists "Financial Statements and Exhibits" as an item information category but does not detail the specific contents of these exhibits.
What is the Commission File Number for NovaBay Pharmaceuticals, Inc.?
The Commission File Number for NovaBay Pharmaceuticals, Inc. is 001-33678.
Where are NovaBay Pharmaceuticals, Inc.'s principal executive offices located?
NovaBay Pharmaceuticals, Inc.'s principal executive offices are located at 2000 Powell Street, Suite 1150, Emeryville, CA 94608.
When was NovaBay Pharmaceuticals, Inc. incorporated?
NovaBay Pharmaceuticals, Inc. was incorporated in Delaware.
Filing Stats: 485 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-10-21 07:00:34
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share NBY NYSE American Indic
- $6.0 million — o have stockholders' equity of at least $6.0 million. The Company has now met this stockhold
Filing Documents
- novabay_8k.htm (8-K) — 28KB
- novabay_ex99-1.htm (EX-99.1) — 9KB
- 0001829126-25-008295.txt ( ) — 200KB
- nby-20251020.xsd (EX-101.SCH) — 3KB
- nby-20251020_lab.xml (EX-101.LAB) — 33KB
- nby-20251020_pre.xml (EX-101.PRE) — 22KB
- novabay_8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 21, 2025 NovaBay Pharmaceuticals, Inc. By: /s/ Tommy Law Name: Tommy Law Title: Chief Financial Officer 2